This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A non-randomized, open-label study to characterize...
Clinical trial

A non-randomized, open-label study to characterize the pharmacokinetics of Glivec/Gleevec� (imatinib mesylate) in pediatric (age range 1 to less than 4 years) patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphobla

Read time: 1 mins
Last updated:9th Mar 2010
To characterize the pharmacokinetics of imatinib in pediatric patients age 1 to less than 4 years via appropriate integrated physiologically-based pharmacokinetic (PBPK) and population pharmacokinetics (pop PK) approaches.
Category Value
Study start date 2010-03-09

View full details